We are pleased to announce Pathology Asia’s inclusion as a member of the Global Diagnostics Network (GDN), a strategic working group of diagnostic laboratories from around the world. Pathology Asia was introduced to this globe-spanning community in July 2023.

Pathology Asia’s membership in the GDN reinforces its commitment to ensuring that healthcare professionals are well-informed when making choices that will shape medical decisions and health diagnoses. It also furthers their goal to become a fully integrated digital healthcare organisation.

The GDN was conceptualised by US-based Quest Diagnostics as a worldwide community of leading healthcare companies.  This worldwide network was designed to develop collaborations among the world’s leading healthcare companies to address the growing need for advanced diagnostic testing and high-quality healthcare services.

Presently, the Network has a presence in countries with two-thirds of the world’s population and over 90% of the global pharmaceutical market.  Its members include Quest Diagnostics, Al Borg Medical Laboratories, Apollo Health & Lifestyle, Dasa, GC Labs, Healius, Lifelabs, LSI Medience , KingMed Diagnostics, Pathology Asia, Strand Life Sciences, and SYNLAB.

Safework Health has been a member of the Pathology Asia group since 2019. The Group is one of the largest and fastest-growing diagnostics groups in the region and comprises leading diagnostic laboratories across Southeast Asia and Australia.